Roche will be launching the Phase III trial to gain approval of Elevidys in Europe and other countries globally.
Acerand Therapeutics has reported updated findings from its first-in-human Phase I/II study of ACE-106 to treat advanced solid tumours.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results